Fig. 7

CMP-specific IgA to casein (a) and ALA (c) increased significantly from pre-therapy to 300 mL challenge with CM (unpaired t test, **P < 0.01 and *P < 0.05 respectively for casein and ALA). Casein (d), BLG (e), and ALA (f) specific IgG4 increased significantly baseline at the completion of OIT (unpaired t test, *p < 0.05, ***p < 0.001, ***p < 0.001 respectively for casein, BLG, and ALA)